These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

246 related articles for article (PubMed ID: 36018231)

  • 21. Psychedelic Therapy: A Primer for Primary Care Clinicians-3,4-Methylenedioxy-methamphetamine (MDMA).
    Shinozuka K; Tabaac BJ; Arenas A; Beutler BD; Cherian K; Evans VD; Fasano C; Muir OS
    Am J Ther; 2024 Mar-Apr 01; 31(2):e141-e154. PubMed ID: 38518271
    [TBL] [Abstract][Full Text] [Related]  

  • 22. MDMA-assisted psychotherapy for treatment of PTSD: study design and rationale for phase 3 trials based on pooled analysis of six phase 2 randomized controlled trials.
    Mithoefer MC; Feduccia AA; Jerome L; Mithoefer A; Wagner M; Walsh Z; Hamilton S; Yazar-Klosinski B; Emerson A; Doblin R
    Psychopharmacology (Berl); 2019 Sep; 236(9):2735-2745. PubMed ID: 31065731
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The cost-effectiveness of MDMA-assisted psychotherapy for the treatment of chronic, treatment-resistant PTSD.
    Marseille E; Kahn JG; Yazar-Klosinski B; Doblin R
    PLoS One; 2020; 15(10):e0239997. PubMed ID: 33052965
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The safety and efficacy of {+/-}3,4-methylenedioxymethamphetamine-assisted psychotherapy in subjects with chronic, treatment-resistant posttraumatic stress disorder: the first randomized controlled pilot study.
    Mithoefer MC; Wagner MT; Mithoefer AT; Jerome L; Doblin R
    J Psychopharmacol; 2011 Apr; 25(4):439-52. PubMed ID: 20643699
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Why MDMA therapy for alcohol use disorder? And why now?
    Sessa B
    Neuropharmacology; 2018 Nov; 142():83-88. PubMed ID: 29126911
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Drug-drug interactions between psychiatric medications and MDMA or psilocybin: a systematic review.
    Sarparast A; Thomas K; Malcolm B; Stauffer CS
    Psychopharmacology (Berl); 2022 Jun; 239(6):1945-1976. PubMed ID: 35253070
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A Review of MDMA-Assisted Therapy for Posttraumatic Stress Disorder.
    Lewis BR; Byrne K
    Focus (Am Psychiatr Publ); 2023 Jul; 21(3):247-256. PubMed ID: 37404966
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Methylenedioxymethamphetamine (MDMA) in Psychiatry: Pros, Cons, and Suggestions.
    Schenk S; Newcombe D
    J Clin Psychopharmacol; 2018 Dec; 38(6):632-638. PubMed ID: 30303861
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Acute subjective effects in LSD- and MDMA-assisted psychotherapy.
    Schmid Y; Gasser P; Oehen P; Liechti ME
    J Psychopharmacol; 2021 Apr; 35(4):362-374. PubMed ID: 33853422
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Treating posttraumatic stress disorder with MDMA-assisted psychotherapy: A preliminary meta-analysis and comparison to prolonged exposure therapy.
    Amoroso T; Workman M
    J Psychopharmacol; 2016 Jul; 30(7):595-600. PubMed ID: 27118529
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A Neuroanatomic and Pathophysiologic Framework for Novel Pharmacological Approaches to the Treatment of Post-traumatic Stress Disorder.
    Norred MA; Zuschlag ZD; Hamner MB
    Drugs; 2024 Feb; 84(2):149-164. PubMed ID: 38413493
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The Emerging Field of Psychedelic Psychotherapy.
    Barber GS; Aaronson ST
    Curr Psychiatry Rep; 2022 Oct; 24(10):583-590. PubMed ID: 36129571
    [TBL] [Abstract][Full Text] [Related]  

  • 33. MDMA-assisted psychotherapy for post-traumatic stress disorder: The devil is in the detail.
    Bedi G; Cotton SM; Guerin AA; Jackson HJ
    Aust N Z J Psychiatry; 2023 Apr; 57(4):476-481. PubMed ID: 36165006
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Psychedelics and Psychedelic-Assisted Psychotherapy.
    Reiff CM; Richman EE; Nemeroff CB; Carpenter LL; Widge AS; Rodriguez CI; Kalin NH; McDonald WM;
    Am J Psychiatry; 2020 May; 177(5):391-410. PubMed ID: 32098487
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Potential Psychiatric Uses for MDMA.
    Yazar-Klosinski BB; Mithoefer MC
    Clin Pharmacol Ther; 2017 Feb; 101(2):194-196. PubMed ID: 27859039
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Why Psychiatry Needs 3,4-Methylenedioxymethamphetamine: A Child Psychiatrist's Perspective.
    Sessa B
    Neurotherapeutics; 2017 Jul; 14(3):741-749. PubMed ID: 28477247
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Sleep Quality Improvements After MDMA-Assisted Psychotherapy for the Treatment of Posttraumatic Stress Disorder.
    Ponte L; Jerome L; Hamilton S; Mithoefer MC; Yazar-Klosinski BB; Vermetten E; Feduccia AA
    J Trauma Stress; 2021 Aug; 34(4):851-863. PubMed ID: 34114250
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A clinical plan for MDMA (Ecstasy) in the treatment of posttraumatic stress disorder (PTSD): partnering with the FDA.
    Doblin R
    J Psychoactive Drugs; 2002; 34(2):185-94. PubMed ID: 12691208
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A randomized, controlled pilot study of MDMA (± 3,4-Methylenedioxymethamphetamine)-assisted psychotherapy for treatment of resistant, chronic Post-Traumatic Stress Disorder (PTSD).
    Oehen P; Traber R; Widmer V; Schnyder U
    J Psychopharmacol; 2013 Jan; 27(1):40-52. PubMed ID: 23118021
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Posttraumatic Growth After MDMA-Assisted Psychotherapy for Posttraumatic Stress Disorder.
    Gorman I; Belser AB; Jerome L; Hennigan C; Shechet B; Hamilton S; Yazar-Klosinski B; Emerson A; Feduccia AA
    J Trauma Stress; 2020 Apr; 33(2):161-170. PubMed ID: 32073177
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.